Amyl Therapeutics Company Profile, Contacts & Intelligence

Amyl Therapeutics Overview

Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.

Headquarters

Be

Website

www.amyltx.com

Industry

Biotechnology Research

Founded

2020

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Amyl Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Amyl Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Amyl Therapeutics Workforce Composition

Seniority breakdown across 3 visible profiles.

Compare Similar Companies to Amyl Therapeutics

Explore companies in related markets and compare their industry and employee estimates.